2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate

C90H135N13O29 — CID 157231121

IUPAC2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate
SMILESCC(=O)OCC1CN(C(=O)CCN)CCN1CC(=O)O.CC(=O)OCC1CN(C(=O)CCN)CCN1CC(=O)OC(C)(C)C.CC(=O)OCC1CN(C(=O)CCNC(=O)OCC2[C@H]3CCC#CCC[C@@H]23)CCN1CC(=O)O.CC(=O)OCC1CN(C(=O)CCNC(=O)OCc2ccccc2)CCN1CC(=O)OC(C)(C)C.O=C(OCC1[C@H]2CCC#CCC[C@@H]12)ON1C(=O)CCC1=O
InChIInChI=1S/C24H35N3O7.C23H33N3O7.C16H29N3O5.C15H17NO5.C12H21N3O5/c1-18(28)32-17-20-14-27(13-12-26(20)15-22(30)34-24(2,3)4)21(29)10-11-25-23(31)33-16-19-8-6-5-7-9-19;1-16(27)32-14-17-12-26(11-10-25(17)13-22(29)30)21(28)8-9-24-23(31)33-15-20-18-6-4-2-3-5-7-19(18)20;1-12(20)23-11-13-9-19(14(21)5-6-17)8-7-18(13)10-15(22)24-16(2,3)4;17-13-7-8-14(18)16(13)21-15(19)20-9-12-10-5-3-1-2-4-6-11(10)12;1-9(16)20-8-10-6-15(11(17)2-3-13)5-4-14(10)7-12(18)19/h5-9,20H,10-17H2,1-4H3,(H,25,31);17-20H,4-15H2,1H3,(H,24,31)(H,29,30);13H,5-11,17H2,1-4H3;10-12H,3-9H2;10H,2-8,13H2,1H3,(H,18,19)/t;17?,18-,19+,20?;;10-,11+,12?;
InChIKeyAUCOBCFBEWTUAB-BUOAJDDGSA-N
MW1863.13 g/mol
LogP2.32
Rot. Bonds33

About 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate

2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate (PubChem CID 157231121) has the molecular formula C90H135N13O29 and a molecular weight of 1863.13 g/mol. Its IUPAC name is 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate.

Molecular Properties

Compound Name2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate
PubChem CID157231121
Molecular FormulaC90H135N13O29
Molecular Weight1863.13 g/mol
Exact Mass1861.95
IUPAC Name2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate
SMILESCC(=O)OCC1CN(C(=O)CCN)CCN1CC(=O)O.CC(=O)OCC1CN(C(=O)CCN)CCN1CC(=O)OC(C)(C)C.CC(=O)OCC1CN(C(=O)CCNC(=O)OCC2[C@H]3CCC#CCC[C@@H]23)CCN1CC(=O)O.CC(=O)OCC1CN(C(=O)CCNC(=O)OCc2ccccc2)CCN1CC(=O)OC(C)(C)C.O=C(OCC1[C@H]2CCC#CCC[C@@H]12)ON1C(=O)CCC1=O
InChIInChI=1S/C24H35N3O7.C23H33N3O7.C16H29N3O5.C15H17NO5.C12H21N3O5/c1-18(28)32-17-20-14-27(13-12-26(20)15-22(30)34-24(2,3)4)21(29)10-11-25-23(31)33-16-19-8-6-5-7-9-19;1-16(27)32-14-17-12-26(11-10-25(17)13-22(29)30)21(28)8-9-24-23(31)33-15-20-18-6-4-2-3-5-7-19(18)20;1-12(20)23-11-13-9-19(14(21)5-6-17)8-7-18(13)10-15(22)24-16(2,3)4;17-13-7-8-14(18)16(13)21-15(19)20-9-12-10-5-3-1-2-4-6-11(10)12;1-9(16)20-8-10-6-15(11(17)2-3-13)5-4-14(10)7-12(18)19/h5-9,20H,10-17H2,1-4H3,(H,25,31);17-20H,4-15H2,1H3,(H,24,31)(H,29,30);13H,5-11,17H2,1-4H3;10-12H,3-9H2;10H,2-8,13H2,1H3,(H,18,19)/t;17?,18-,19+,20?;;10-,11+,12?;
InChIKeyAUCOBCFBEWTUAB-BUOAJDDGSA-N
XLogP2.32
TPSA528.21 Ų
H-Bond Donors6
H-Bond Acceptors33
Rotatable Bonds33
Heavy Atoms132
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001863.13
LogP ≤ 52.32
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate?
The IUPAC name of 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate (CID 157231121) is 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate.
What is the SMILES notation for 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate?
The canonical SMILES for 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate is CC(=O)OCC1CN(C(=O)CCN)CCN1CC(=O)O.CC(=O)OCC1CN(C(=O)CCN)CCN1CC(=O)OC(C)(C)C.CC(=O)OCC1CN(C(=O)CCNC(=O)OCC2[C@H]3CCC#CCC[C@@H]23)CCN1CC(=O)O.CC(=O)OCC1CN(C(=O)CCNC(=O)OCc2ccccc2)CCN1CC(=O)OC(C)(C)C.O=C(OCC1[C@H]2CCC#CCC[C@@H]12)ON1C(=O)CCC1=O.
What is the InChIKey of 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate?
The InChIKey is AUCOBCFBEWTUAB-BUOAJDDGSA-N. The full InChI is InChI=1S/C24H35N3O7.C23H33N3O7.C16H29N3O5.C15H17NO5.C12H21N3O5/c1-18(28)32-17-20-14-27(13-12-26(20)15-22(30)34-24(2,3)4)21(29)10-11-25-23(31)33-16-19-8-6-5-7-9-19;1-16(27)32-14-17-12-26(11-10-25(17)13-22(29)30)21(28)8-9-24-23(31)33-15-20-18-6-4-2-3-5-7-19(18)20;1-12(20)23-11-13-9-19(14(21)5-6-17)8-7-18(13)10-15(22)24-16(2,3)4;17-13-7-8-14(18)16(13)21-15(19)20-9-12-10-5-3-1-2-4-6-11(10)12;1-9(16)20-8-10-6-15(11(17)2-3-13)5-4-14(10)7-12(18)19/h5-9,20H,10-17H2,1-4H3,(H,25,31);17-20H,4-15H2,1H3,(H,24,31)(H,29,30);13H,5-11,17H2,1-4H3;10-12H,3-9H2;10H,2-8,13H2,1H3,(H,18,19)/t;17?,18-,19+,20?;;10-,11+,12?;.
What are the key properties of 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate?
2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate has a molecular weight of 1863.13 g/mol, XLogP of 2.32, 33 rotatable bonds, 6 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetic acid;2-[2-(acetyloxymethyl)-4-[3-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylamino]propanoyl]piperazin-1-yl]acetic acid;[(1S,8R)-9-bicyclo[6.1.0]non-4-ynyl]methyl (2,5-dioxopyrrolidin-1-yl) carbonate;tert-butyl 2-[2-(acetyloxymethyl)-4-(3-aminopropanoyl)piperazin-1-yl]acetate;tert-butyl 2-[2-(acetyloxymethyl)-4-[3-(phenylmethoxycarbonylamino)propanoyl]piperazin-1-yl]acetate is sourced from PubChem (CID 157231121), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).